Denali Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Denali Therapeutics Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory vote.
NASDAQ
Denali Therapeutics Inc. has filed definitive additional materials related to its proxy statement with the Securities and Exchange Commission.
NASDAQ
Denali Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 3, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
Denali Therapeutics Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Denali Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on May 31, 2024, to vote on director elections, auditor ratification, and executive compensation.